BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Leukemia
,
Leukocyte
,
Amniocentesis
,
Valproic acid
,
rs2476601
,
KLK3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cardiovascular agents
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
FOS
ATF3
EGR1
CYP1A1
HMGCS1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
regulation of nitrogen compound metabolic process
organic cyclic compound binding
PILON_KLF1_TARGETS_DN
heterocyclic compound binding
organic cyclic compound metabolic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Embryonic stem cells in response to programming factors butyrate and DZNep
Hepatocyte growth factor (HCF)-induced changes in gene expression in DU145 prostate cancer cells
Butyrate mediated prevention of colorectal cancer in a mouse model
Lungs of mice exposed to chronic cigarette smoke with/without Losartan treatment
Ovarian cancer cell lines responses to norepinephrine
Explore Curated Studies Results
Literature
Most Relevant Literature
Pharmacogenetics of cardiovascular drugs.
Role of the gut microbiome in cardiovascular drug response: The potential for clinical application.
Access to cardiovascular medicines in low- and middle-income countries: a mini review.
Guiding future paediatric drug studies based on existing pharmacokinetic and efficacy data: Cardiova…
Pharmacogenetics to guide cardiovascular drug therapy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic He…
Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients
Comparison Between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes Following…
Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ